The antibacterial medicine market in Germany is forecasted to decline from $746.7 million in 2024 to $682.1 million by 2028. This represents a year-on-year decrease of approximately 2%-3% over the forecast period. Compared to the pre-2024 situation, where the market size was more robust, this trend reflects a significant reduction in market size, indicative of potential saturation or reduced demand.
- The total compound annual growth rate (CAGR) from 2024 to 2028 is approximately -2.2%, emphasizing the declining trend.
Future trends to watch for include advancements in alternative therapies, increasing regulatory measures on antibiotic usage, and a greater focus on combating antimicrobial resistance, which may further impact sales negatively.
